Search by Drug Name or NDC

NDC 72789-0171-82 Lithium Carbonate 300 mg/1 Details

Lithium Carbonate 300 mg/1

Lithium Carbonate is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is LITHIUM CARBONATE.

MedlinePlus Drug Summary

Lithium is used to treat and prevent episodes of mania (frenzied, abnormally excited mood) in people with bipolar disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Lithium is in a class of medications called antimanic agents. It works by decreasing abnormal activity in the brain.

Related Packages: 72789-0171-82
Last Updated: 05/19/2024
MedLinePlus Full Drug Details: Lithium

Product Information

NDC	72789-0171
Product ID	72789-171_0b293129-7212-ac60-e063-6294a90ae92f
Associated GPIs	59500010100405
GCN Sequence Number	004004
GCN Sequence Number Description	lithium carbonate TABLET ER 300 MG ORAL
HIC3	H2M
HIC3 Description	BIPOLAR DISORDER DRUGS
GCN	15731
HICL Sequence Number	001669
HICL Sequence Number Description	LITHIUM CARBONATE
Brand/Generic	Generic
Proprietary Name	Lithium Carbonate
Proprietary Name Suffix	n/a
Non-Proprietary Name	Lithium Carbonate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, EXTENDED RELEASE
Route	ORAL
Active Ingredient Strength	300
Active Ingredient Units	mg/1
Substance Name	LITHIUM CARBONATE
Labeler Name	PD-Rx Pharmaceuticals, Inc.
Pharmaceutical Class	Mood Stabilizer [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA076832
Listing Certified Through	2024-12-31

Package

NDC 72789-0171-82 (72789017182)

Pricing Information	N/A
NDC Package Code	72789-171-82
Billing NDC	72789017182
Package	500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (72789-171-82)
Marketing Start Date	2023-08-23
NDC Exclude Flag	N